Kamala Thriemer is a clinical researcher committed to public health and tropical medicine. She has more than 10 years field experience in Africa and Asia, coordinating clinical trials to inform treatment of the management of infectious diseases. She started her research career at the International Center for Diarrheal Diseases (icddr,b) in Bangladesh focusing on clinical and epidemiological studies to define the burden of falciparum malaria. She subsequently worked with the International Vaccine Institute (IVI) based in Tanzania and Kenya and then at the Institute for Tropical Medicine (ITM), Belgium where her research interests included malaria, typhoid fever and cholera. Her current research at Menzies focuses on optimising the treatment of P. vivax and developing public health strategies for malaria elimination. She is also a lecturer at Charles Darwin University and coordinates the Vivax Working Group (VxWG) of the Asia Pacific Malaria Elimination Network (APMEN).Related Publications
- A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria
- A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria
- Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
- An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
- Economic costs of vivax malaria episodes: A multi-country comparative analysis using primary trial data
- Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia
- Glucose-6-Phosphate Dehydrogenase (G6PD) Measurement Using Biosensors by Community-Based Village Malaria Workers and Hospital Laboratory Staff in Cambodia: A Quantitative Study
- Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh
- Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis
- Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas – a radomised controlled trial
- Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
- Study protocol for development of an options assessment toolkit (OAT) for national malaria programs in Asia Pacific to determine best combinations of vivax radical cure for their given contexts
- Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
- The efficacy of dihydroartemisininpiperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
- The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
- The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network
- Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria